Newsbot

» Nachrichtenticker öffnen

Telsey CEO: Prices to Keep Rising Into 2026

Dana Telsey, Telsey Advisory Group Founder and CEO, says prices are likely to keep rising into 2026 as higher costs work through the system and tariffs imposed in April continue to weigh on prices. She speaks with Carol Massar on "Bloomberg Markets." (Source: Bloomberg)

Tariffs Functioning as a Sort of ‘Deterrent’: Lucier

James Lucier, Capital Alpha Partners founding partner, says the Supreme Court may strike down both the China-related national security tariffs and reciprocal tariffs imposed under emergency economic powers. He speaks with Carol Massar on "Bloomberg Markets." (Source: Bloomberg)

Musks xAI buys third building to expand AI compute power

Elon Musk said on Tuesday his artificial intelligence startup xAI has bought a third building to expand its infrastructure, aiming to boost training capacity to nearly 2 gigawatts of compute power.

AIM ImmunoTech Announces Stock Dividend

OCALA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) --  AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a stock dividend of one share of common stock for every 1,000 shares of outstanding common stock as well as one share of common stock for every outstanding option or warrant that has a right to receive stock dividends (“Alternate Securities”). The dividend will be issuable to stockholders and Alternate Securities holders of record at the close of business on January...

Higher Income Consumers Continuing to Spend, Say Dana Telsey

Dana Telsey, Founder and CEO of Telsey Advisory Group, says she expects price increases into 2026. The high cost of living and angst about the job market are keeping consumer sentiment near record lows. Concerns about personal finances pose a risk to the outlook for household spending which has otherwise held up. Payroll growth remained sluggish in November and the jobless rate rose to a four-year high of 4.6%. Economists anticipate that job growth will remain tepid next year and the unemploym...

Geopolitik macht Sorgen: Wall Street bleibt im Schwächemodus

Die Aussicht auf eine rauschende Silvesterfeier hat die Laune der US-Anleger nicht gehoben. Zum Jahresausklang dominieren düstere geopolitische Nachrichten an der Wall Street. Auch die Hoffnungen auf eine schnelle Zinssenkung im neuen Jahr sind bescheiden.

Ellomay Capital Reports Results for the Three and Nine Months Ended September 30, 2025

TEL-AVIV, Israel, Dec. 30, 2025 (GLOBE NEWSWIRE) -- TEL-AVIV, Israel, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and the USA, today reported its unaudited interim consolidated financial results for the three and nine month periods ended September 30, 2025.

Entscheidung über Luftkampfsystem FCAS erneut verschoben

BERLIN (dpa-AFX) - Deutschland und Frankreich haben die Entscheidung über das europäische Luftkampfsystem FCAS erneut vertagt - diesmal auf einen unbestimmten Zeitpunkt. "Entgegen der ursprünglichen Planung ist eine abschließende Entscheidung zum For...

CGE Energy, Inc and Aradatum, Inc 2025 Year End Update

BRIGHTON, Mich, Dec. 30, 2025 (GLOBE NEWSWIRE) -- CGE Energy, Inc. (OTC: CGEI) today announced the issuance of the following year end update letter from its President and Chief Executive Officer, Bryan Zaplitny.

Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference

NORTHFIELD, Ill., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are scheduled to present at the J.P. Morgan Healthcare Conference in San Francisco, Calif., on Tuesday, January 13, 2026, at 3:00 pm Pacific Time.

Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference

SUNNYVALE, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation will take place on Monday, January 12, 2026, at 9:00 am Pacific Standard Time / 12:00 pm Eastern Sta...

Treace to Present at 44th Annual J.P. Morgan Healthcare Conference

PONTE VEDRA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that John T. Treace, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, beginning at approximately 7:30 am PT.